CCP
DXCM icon

Carmel Capital Partners’s DexCom DXCM Stock Holding History

Carmel Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$1.68K – 295
2023
Q3 		$1.68K Hold
18
– – ﹤0.01% 639
2023
Q2 		$2.31K Hold
18
– – ﹤0.01% 355
2023
Q1 		$2.09K Buy
+18
New +$2.02K ﹤0.01% 405

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmel Capital Partners's DXCM Position: Q4 2023 in Review

Carmel Capital Partners sold out of DexCom (DXCM) in Q4 2023, closing a stake of 18 shares — an estimated $1.68K sold.

Carmel Capital Partners first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $2.31K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Carmel Capital Partners reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 18 DexCom shares in Q4 2023, an estimated $1.68K.
  • Carmel Capital Partners first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • Carmel Capital Partners's DexCom position peaked at $2.31K in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.